WHO announces cheaper drug treatment for multidrug resistant tuberculosis

The World Health Organization (WHO) has published new recommendations that seek to speed up detection and enhance cure rates for patients with multidrug resistant tuberculosis (MDR-TB).
The WHO recommends the use of a shorter and cheaper treatment regimen, which is taken for 9–12 months,…